LifeVantage Corporation
LifeVantage Corporation (LFVN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · LFVN · as of Sep 30, 2025
Ownership Breakdown
108
Institutional Holders
▼ 5 vs Q2
$71.33M
Total Inst. Value
▼ $25.14M vs Q2
12.62M
Shares Outstanding
freeFloat 83.19%
7.33M
13F Shares Held
▼ 50,409 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
LFVN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
CAPITAL MANAGEMENT CORP /VA pharmaceutical preparations | 2.06M | 16.75% | 16.75% | $20.08B | Nov 4, 2025 | ▲ 798.1K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 852.0K | 6.91% | 6.91% | $8.29B | Nov 13, 2025 | ▼ 42.4K |
BLACKROCK, INC. pharmaceutical preparations | 748.8K | 6.08% | 6.08% | $7.29B | Nov 12, 2025 | ▲ 149.1K |
VANGUARD GROUP INC pharmaceutical preparations | 561.1K | 4.55% | 4.55% | $5.46B | Nov 7, 2025 | ▼ 3.3K |
DIMENSIONAL FUND ADVISORS LP pharmaceutical preparations | 292.6K | 2.37% | 2.37% | $2.85B | Nov 12, 2025 | ▼ 343 |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 243.6K | 1.98% | 1.98% | $2.37B | Nov 12, 2025 | ▼ 1.8K |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 242.7K | 1.97% | 1.97% | $2.36B | Nov 14, 2025 | ▼ 48.8K |
STATE STREET CORP pharmaceutical preparations | 167.7K | 1.36% | 1.36% | $1.63B | Nov 14, 2025 | ▲ 54.8K |
ENVESTNET ASSET MANAGEMENT INC pharmaceutical preparations | 111.8K | 90.67% | 90.67% | $1.09B | Nov 5, 2025 | ▲ 7.1K |
AMERICAN CENTURY COMPANIES INC pharmaceutical preparations | 107.6K | 87.28% | 87.28% | $1.05B | Nov 12, 2025 | ▼ 12.1K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
19
Increased
+1.14M shares4
New Positions
first time holders21
Decreased
−637.0K shares0
Sold Out
fully exitedNet shares change (top 50)
+504.1K
+1.14M / −637.0K
Net new holders
+2
4 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
LFVN insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
5
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
BEINDORFF MICHAEL A director | Jun 3, 2026 | Sale | 10,000 | $8.55 | $85.5K | 41.6K | Form 4 ↗ |
Fife Steven R President and CEO | Apr 1, 2026 | Tax Withhold | 8,180 | $4.20 | $34.4K | 735.5K | Form 4 ↗ |
Neufeld Alissa General Counsel | Apr 1, 2026 | Tax Withhold | 1,446 | $4.20 | $6.1K | 114.1K | Form 4 ↗ |
Aure Carl Chief Financial Officer | Apr 1, 2026 | Tax Withhold | 1,527 | $4.20 | $6.4K | 156.9K | Form 4 ↗ |
Cunningham Kristen Chief Sales Officer | Apr 1, 2026 | Tax Withhold | 1,928 | $4.20 | $8.1K | 133.1K | Form 4 ↗ |
Lewis Darwin director | Mar 16, 2026 | Purchase | 1,055 | $5.23 | $5.5K | 136.6K | Form 4 ↗ |
Dayton Judd director | Mar 2, 2026 | Purchase | 10,500 | $4.53 | $47.6K | 80.4K | Form 4 ↗ |
Dayton Judd director | Feb 27, 2026 | Purchase | 18,097 | $4.63 | $83.8K | 69.9K | Form 4 ↗ |
Dayton Judd director | Feb 26, 2026 | Purchase | 4,600 | $4.58 | $21.1K | 51.8K | Form 4 ↗ |
Lewis Darwin director | Feb 9, 2026 | Purchase | 3,955 | $5.22 | $20.7K | 135.5K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
LifeVantage Corporation (LFVN) is primarily owned by institutional investors, who hold approximately 58.1% of total shares outstanding. Company insiders own approximately 16.81%, while retail and public investors account for the remaining 25.11%.
The largest institutional shareholder of LifeVantage Corporation is CAPITAL MANAGEMENT CORP /VA, holding approximately 2.06 million shares — equal to 16.75% of outstanding shares — as of September 30, 2025.
A total of 108 institutional investors currently hold LFVN stock, with a combined institutional value of approximately $71,332,578 as of the most recent 13F filing period.
Frequently asked questions
LFVN ownershipLifeVantage Corporation (LFVN) is primarily owned by institutional investors, who hold approximately 58.1% of shares. The largest shareholder is CAPITAL MANAGEMENT CORP /VA with a 16.75% stake. Company insiders hold 16.81%. Data sourced from SEC Form 13F as of September 30, 2025.